Skip to content

Clinical and Radiological Outcomes of Mecta-C Stand Alone implants

Clinical and Radiological Outcomes of Mecta-C Stand Alone implants - Mecta C SA study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028910
Enrollment
100
Registered
2022-12-28
Start date
2022-06-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CERVICAL DEGENERATIV EDISC DISEASE

Interventions

Group 1: Patients requiring an anterior cervical discectomy and fusion (ACDF) procedure and who are suitable to receive the Medacta Mecta-C Stand Alone implant

Sponsors

Medacta Internaional
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Both genders • Older than 18 years • Degenerative disk disease at minimum one level from C2 to T1 and with at least six weeks of non-operative treatment • Patients requiring ACDF procedures according to manufacturer’s IFU • Patients willing and able to sign the written informed consent

Exclusion criteria

Exclusion criteria: • Physical conditions that could delay healing or impair the implant’s success according to manufacturer’s IFU • Patients’ inability, in the opinion of the investigator, to comply with the study schedule • Patients with malignant diseases (at the time of surgery) • Patients with proven or suspected infections (at the time of surgery) • Foreign body sensitivity, known or suspected allergies to implant and/or instrument materials

Design outcomes

Primary

MeasureTime frame
To evaluate the percentage of success in getting bone fusion at 6 months.

Secondary

MeasureTime frame
To assess clinical and functional outcomes. To assess neck and arm pain. To assess radiological outcomes (optional). To evaluate device-related complications.

Countries

Austria, Germany

Contacts

Public ContactElisa Bonacina

Medacta International

myclinicaldata@medacta.ch+41916966060

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026